In the last 12 months, insiders at Entera Bio Ltd. ($ENTX) filed 85 transactions with the SEC: 18 open-market purchases totaling $267,463 and 0 sales totaling $0. Net insider sentiment: net buying.
Entera Bio Ltd. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Toledano Miranda Jayne (Chief Executive Officer) — 10 transactions totaling $67,218
- Ellis Sean (Director) — 11 transactions totaling $58,620
- Germano Geno J (Director) — 2 transactions totaling $55,800
- LIEBERMAN GERALD M (Director) — 13 transactions totaling $52,742
- Taitel Haya (Director) — 12 transactions totaling $37,584
View all SEC Filings for Entera Bio Ltd. (ENTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Germano Geno J | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 20000 | $1.30 | 40,000.0000 | 47,089,814 | 100.00% | 0.04% |
| March 5, 2026 | Ellis Sean | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 10000 | $1.23 | 188,098.0000 | 47,089,814 | 5.61% | 0.02% |
| Feb. 12, 2026 | Rubin Steven D | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 5000 | $1.49 | 15,000.0000 | 47,089,814 | 50.00% | 0.01% |
| Feb. 10, 2026 | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 7500 | $1.48 | 98,479.0000 | 47,089,814 | 8.24% | 0.02% |
| Feb. 9, 2026 | Ellis Sean | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 18000 | $1.24 | 178,098.0000 | 47,089,814 | 11.24% | 0.04% |
| Feb. 10, 2026 | Germano Geno J | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 20000 | $1.49 | 20,000.0000 | 47,089,814 | 9999.99% | 0.04% |
| Feb. 9, 2026 | Rubin Steven D | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 10000 | $1.20 | 10,000.0000 | 47,089,814 | 9999.99% | 0.02% |
| Jan. 1, 2026 | OSTROV GERALD M | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 1, 2026 | OSTROV GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 28721 | $0.00 | 75,657.0000 | 47,089,814 | 61.19% | 0.06% |
| Jan. 1, 2026 | Taitel Haya | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 1, 2026 | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 1, 2026 | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 38294 | $0.00 | 363,254.0000 | 47,089,814 | 11.78% | 0.08% |
| Jan. 1, 2026 | Malca Yonatan | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 1, 2026 | Malca Yonatan | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 30157 | $0.00 | 77,416.0000 | 47,089,814 | 63.81% | 0.06% |
| Jan. 1, 2026 | Ellis Sean | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 1, 2026 | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 25371 | $0.00 | 160,098.0000 | 47,089,814 | 18.83% | 0.05% |
| Jan. 1, 2026 | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 26329 | $0.00 | 90,979.0000 | 47,089,814 | 40.73% | 0.06% |
| Dec. 29, 2025 | Toledano Miranda Jayne | Chief Executive Officer | P | Ordinary Shares, par value NIS 0.0000769 per share | 11000 | $1.81 | 426,575.0000 | 47,089,814 | 2.65% | 0.02% |
| July 16, 2025 | Toledano Miranda Jayne | Chief Executive Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 37,650,179 | 9999.99% | 1.33% |
| July 16, 2025 | Burshtein Gregory | Chief of R&D | A | Ordinary Shares, par value NIS 0.0000769 per share | 26316 | $0.00 | 101,442.0000 | 37,650,179 | 35.03% | 0.07% |
| July 16, 2025 | Burshtein Gregory | Chief of R&D | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 37,650,179 | 9999.99% | 0.53% |
| July 16, 2025 | Yaacov-Garbeli Dana | Chief Financial Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 26316 | $0.00 | 113,047.0000 | 37,650,179 | 30.34% | 0.07% |
| July 16, 2025 | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 37,650,179 | 9999.99% | 0.35% |
| July 16, 2025 | Toledano Miranda Jayne | Chief Executive Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 136842 | $0.00 | 371,715.0000 | 37,650,179 | 58.26% | 0.36% |
| July 16, 2025 | Toledano Miranda Jayne | Chief Executive Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 43860 | $0.00 | 415,575.0000 | 37,650,179 | 11.80% | 0.12% |
| April 28, 2025 | Galitzer Hillel | Chief Operating Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 37,650,179 | 9999.99% | 0.27% |
| April 28, 2025 | Galitzer Hillel | Chief Operating Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 26316 | $0.00 | 90,573.0000 | 37,650,179 | 40.95% | 0.07% |
| April 1, 2025 | LIEBERMAN GERALD M | Director | M | Warrant (right to buy) | 23952 | $0.00 | 28,509.0000 | 37,650,179 | 45.66% | 0.06% |
| April 1, 2025 | LIEBERMAN GERALD M | Director | M | Ordinary Shares, par value NIS 0.0000769 per share | 23952 | $1.00 | 324,960.0000 | 37,650,179 | 7.96% | 0.06% |
| Jan. 15, 2025 | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 10717 | $0.00 | 301,008.0000 | 37,650,179 | 3.69% | 0.03% |
| Jan. 15, 2025 | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 6922 | $0.00 | 64,650.0000 | 37,650,179 | 11.99% | 0.02% |
| Jan. 15, 2025 | Taitel Haya | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Jan. 15, 2025 | OSTROV GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 8038 | $0.00 | 46,936.0000 | 37,650,179 | 20.66% | 0.02% |
| Jan. 15, 2025 | OSTROV GERALD M | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Jan. 15, 2025 | Malca Yonatan | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 8216 | $0.00 | 47,259.0000 | 37,650,179 | 21.04% | 0.02% |
| Jan. 15, 2025 | Malca Yonatan | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Jan. 15, 2025 | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Jan. 15, 2025 | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 7100 | $0.00 | 134,727.0000 | 37,650,179 | 5.56% | 0.02% |
| Jan. 15, 2025 | Ellis Sean | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Oct. 2, 2024 | Malca Yonatan | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 8639 | $0.00 | 39,043.0000 | 37,644,612 | 28.41% | 0.02% |
| Oct. 2, 2024 | OSTROV GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 8452 | $0.00 | 38,898.0000 | 37,644,612 | 27.76% | 0.02% |
| Oct. 2, 2024 | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 7278 | $0.00 | 57,728.0000 | 37,644,612 | 14.43% | 0.02% |
| Oct. 2, 2024 | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 7466 | $0.00 | 127,627.0000 | 37,644,612 | 6.21% | 0.02% |
| Oct. 2, 2024 | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 11269 | $0.00 | 290,291.0000 | 37,644,612 | 4.04% | 0.03% |
| Aug. 27, 2024 | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 27261 | $0.00 | 279,022.0000 | 29,007,794 | 10.83% | 0.09% |
| Aug. 27, 2024 | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 15335 | $0.00 | 50,450.0000 | 29,007,794 | 43.67% | 0.05% |
| Aug. 27, 2024 | Malca Yonatan | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 23172 | $0.00 | 30,404.0000 | 29,007,794 | 320.41% | 0.08% |
| Aug. 27, 2024 | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 18061 | $0.00 | 120,161.0000 | 29,007,794 | 17.69% | 0.06% |
| Aug. 27, 2024 | OSTROV GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 20446 | $0.00 | 30,446.0000 | 29,007,794 | 204.46% | 0.07% |
| July 31, 2024 | Toledano Miranda Jayne | Chief Executive Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 29,007,794 | 9999.99% | 1.72% |
| April 19, 2024 | Yaacov-Garbeli Dana | Chief Financial Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 30151 | $0.00 | 86,731.0000 | 29,007,794 | 53.29% | 0.10% |
| July 31, 2024 | Toledano Miranda Jayne | Chief Executive Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 124121 | $0.00 | 234,873.0000 | 29,007,794 | 112.07% | 0.43% |
| April 19, 2024 | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 29,007,794 | 9999.99% | 0.45% |
| April 19, 2024 | Galitzer Hillel | Chief Operating Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 30151 | $0.00 | 64,257.0000 | 29,007,794 | 88.40% | 0.10% |
| April 19, 2024 | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 29,007,794 | 9999.99% | 0.45% |
| April 19, 2024 | Yaacov-Garbeli Dana | Chief Financial Officer | A | Ordinary Shares, par value NIS 0.0000769 per share | 30151 | $0.00 | 86,731.0000 | 29,007,794 | 53.29% | 0.10% |
| April 19, 2024 | Galitzer Hillel | Chief Operating Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 29,007,794 | 9999.99% | 0.45% |
| Jan. 12, 2024 | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 9500 | $0.99 | 35,115.0000 | 29,007,794 | 37.09% | 0.03% |
| Jan. 10, 2024 | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 7615 | $0.77 | 25,615.0000 | 29,007,794 | 42.31% | 0.03% |
| Jan. 1, 2024 | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Jan. 1, 2024 | Mayron Ron | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Jan. 1, 2024 | OSTROV GERALD M | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Jan. 1, 2024 | Ellis Sean | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Jan. 1, 2024 | Malca Yonatan | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Jan. 1, 2024 | Taitel Haya | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Jan. 1, 2024 | GARCEAU ROGER | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Dec. 22, 2023 | LIEBERMAN GERALD M | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 23952 | $0.71 | 251,761.0000 | 0 | 10.51% | 0.00% |
| Dec. 22, 2023 | LIEBERMAN GERALD M | Director | P | Warrants (right to buy) | 23952 | $0.13 | 23,952.0000 | 0 | 9999.99% | 0.00% |
| Dec. 22, 2023 | Toledano Miranda Jayne | Chief Executive Officer | P | Ordinary Shares, par value NIS 0.0000769 per share | 23952 | $0.71 | 110,752.0000 | 0 | 27.59% | 0.00% |
| Dec. 22, 2023 | Toledano Miranda Jayne | Chief Executive Officer | P | Warrants (right to buy) | 23952 | $0.13 | 23,952.0000 | 0 | 9999.99% | 0.00% |
| Sept. 13, 2023 | Taitel Haya | Director | A | Stock Option (right to buy) | 33368 | $0.00 | 33,368.0000 | 0 | 9999.99% | 0.00% |
| Sept. 13, 2023 | Toledano Miranda Jayne | Chief Executive Officer | A | Stock Option (right to buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2023 | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 18000 | $0.62 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 21, 2023 | LIEBERMAN GERALD M | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 20000 | $0.59 | 239,009.0000 | 0 | 9.13% | 0.00% |
| Aug. 21, 2023 | Ellis Sean | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 40000 | $0.60 | 102,100.0000 | 0 | 64.41% | 0.00% |
| April 24, 2023 | Galitzer Hillel | Chief Operating Officer | A | Stock Option (right to buy) | 210000 | $0.00 | 210,000.0000 | 0 | 9999.99% | 0.00% |
| April 24, 2023 | Yaacov-Garbeli Dana | Chief Financial Officer | A | Stock Option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| April 24, 2023 | Santora Arthur C II | Chief Medical Officer | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2023 | Toledano Miranda Jayne | Chief Executive Officer | P | Ordinary Shares, par value NIS 0.0000769 per share | 30000 | $1.01 | 86,800.0000 | 0 | 52.82% | 0.00% |
| Jan. 2, 2023 | Malca Yonatan | Director | A | Stock Option (right to buy) | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2023 | GARCEAU ROGER | Director | A | Stock Option (right to buy) | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2023 | OSTROV GERALD M | Director | A | Stock Option (right to buy) | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2023 | Mayron Ron | Director | A | Stock Option (right to buy) | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2023 | Ellis Sean | Director | A | Stock Option (right to buy | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2023 | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |